Elon Musk's brain implant company Neuralink says it has US approval to begin trials in people

  • 📰 9NewsSyd
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

Argentina Noticias Noticias

Argentina Últimas Noticias,Argentina Titulares

Elon Musk’s brain implant company Neuralink says it's received permission from US regulators to begin testing its device in people. 9News

’s brain implant company Neuralink says it's received permission from US regulators to begin testing its device in people.

Neuralink is one of many groups working on linking the nervous system to computers, efforts aimed at helping treat brain disorders, overcoming brain injuries and other applications. The device is about the size of a large coin and is designed to be implanted in the skull, with ultra-thin wires going directly into the brain.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 23. in AR
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Elon Musk’s brain implant company Neuralink approved for in-human studyThe Food and Drug Administration, which had initially rejected the application, finally gave the company the green light
Fuente: GuardianAus - 🏆 1. / 98 Leer más »

Elon Musk's brain implant company Neuralink says it has US approval to begin trials in peopleElon Musk&x27;s brain implant company Neuralink says it&x27;s received permission from US regulators to begin testing its device in people.
Fuente: 9NewsAUS - 🏆 10. / 72 Leer más »

Elon Musk’s brain implant company wins US approval for trials in humansThe device is about the size of a large coin and is designed to be implanted in the skull, with ultra-thin wires going directly into the brain.
Fuente: theage - 🏆 8. / 77 Leer más »